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Abstract
Background: Non-communicable diseases (NCDs) are the largest cause of premature death worldwide.
Socioeconomic inequalities contribute to a disparity in the burden of NCDs among disadvantaged and advantaged
populations in low (LIC), middle (MIC), and high income countries (HIC). We conducted an overview of systematic
reviews to systematically and objectively assess the available evidence on socioeconomic inequalities in relation to
morbidity and mortality of NCDs and their risk factors.
Methods: We searched PubMed, The Cochrane Library, EMBASE, SCOPUS, Global Health, and Business Source
Complete for relevant systematic reviews published between 2003 and December 2013. Two authors
independently screened abstracts and full-text publications and determined the risk of bias of the included
systematic reviews.
Results: We screened 3302 abstracts, 173 full-text publications and ultimately included 22 systematic reviews. Most
reviews had major methodological shortcomings; however, our synthesis showed that having low socioeconomic
status (SES) and/or living in low and middle income countries (LMIC) increased the risk of developing cardiovascular
diseases (CVD), lung and gastric cancer, type 2 diabetes, and chronic obstructive pulmonary disease (COPD).
Furthermore, low SES increased the risk of mortality from lung cancer, COPD, and reduced breast cancer survival in
HIC. Reviews included here indicated that lower SES is a risk factor for obesity in HIC, but this association varied by
SES measure. Early case fatalities of stroke were lower and survival of retinoblastoma was higher in MIC compared
to LIC.
Conclusions: The current evidence supports an association between socioeconomic inequalities and NCDs and risk
factors for NCDs. However, this evidence is incomplete and limited by the fairly low methodological quality of the
systematic reviews, including shortcomings in the study selection and quality assessment process.
Background
In 2012, non-communicable diseases (NCDs) were re-
sponsible for 38 million deaths globally [1]. The main
chronic diseases contributing to NCD deaths were cardio-
vascular diseases (CVD), cancers, diabetes, and respiratory
diseases, including asthma and chronic obstructive pul-
monary disease (COPD). NCDs have historically been
considered a problem of high income countries (HIC);
however, the proportion of morbidity caused by NCDs in
low and middle income countries (LMIC) is increasing
[2]. Indeed, NCD mortality in LMIC now exceeds that of
communicable diseases – with the exception of the
African Region [1]. Based on recent estimates, nearly three
quarters of all NCD deaths (28 million) were recorded in
LMIC, 82 % of which were premature [1].
Behavioural risk factors for NCDs are well established
and operate in a similar manner in all regions of the world
[3]. The World Health Organization (WHO) has prioritised
action on four risk factors that are shared among the four
major NCDs: tobacco use, physical inactivity, the harmful
use of alcohol, and unhealthy diets [1]. Six million people
are currently estimated to die annually from tobacco use,
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and more than half of the deaths occurring in LMIC [1].
Likewise, physical inactivity caused 2.6 million deaths in
LMIC and 0.6 million deaths in HIC. Harmful use of
alcohol and unhealthy diets as measured by low fruit and
vegetable consumption were also leading risk factors for
mortality in middle income countries (MIC) and HIC [4].
Many studies have documented that lower socioeco-
nomic status is associated with poorer health. Whilst
this association is found in almost every country, the
magnitude of inequality can be more pronounced in
some countries than others [5, 6]. This is likely due to
inequalities in living conditions more broadly that are
generated by political, economic, social, and cultural
factors [5]. For example, data derived from the 2002 to
2004 World Health Survey across LMIC showed that
persons with lower wealth or education levels had
higher prevalence of angina pectoris, arthritis, asthma,
depression and comorbidity, but lower prevalence of
diabetes than persons with higher wealth or education
levels. At the same time, wealth and education inequal-
ities were greater in low income countries (LIC) than
MIC [2].
The aim of this work was to produce an overview of
evidence on socioeconomic inequalities in the 1) inci-
dence and prevalence as well as 2) adverse outcomes of
the four main NCDs, and 3) incidence and prevalence
of their risk factors, both within HIC and LMIC, and
among them. This evidence is particulary important
in terms of determining and monitoring inequalities in
the burden of these diseases, and their risk factors
across social groups and income levels of countries.
This report is the first to summarise evidence on this
level. We aimed to clarify what is already known about
inequalities in NCDs, assess the magnitude of the
problem, and highlight gaps in the evidence in order to
inform priority areas for future research.
Methods
Search strategy
We searched PubMed, The Cochrane Library, EMBASE,
SCOPUS, Global Health, and Business Source Complete
from 2003 until December 2013. We limited electronic
searches to human populations, systematic reviews, and
English, German or Italian language (based on the lan-
guage capabilities of the review team). Additionally, we
screened reference lists of related narrative reviews iden-
tified during the study selection process. The full search
strategy is presented in Additional file 1.
Inclusion and exclusion criteria
We included only systematic reviews with a clear focus on
inequality [7]. The factors determining socioeconomic
status that we considered were: education, occupation,
income, insurance status, and other indirect SES
measures such as housing condition or maternal
marital status [8]. We did not make any restrictions
in the type of SES indicator, such as individual,
household, neighbourhood or population level. We
included systematic reviews on the following NCDs:
CVD, cancers, type 2 diabetes, and chronic respira-
tory diseases (asthma and COPD), all of which ac-
count for the most NCD-related deaths globally [1].
Eligible risk factors for NCDs included: tobacco use,
alcohol consumption, and obesity. We excluded reviews
on specific populations such as prisoners, pregnant
women, or children with disabilities.
Selection strategy
Two persons independently reviewed abstracts and full-
text articles against our pre-specified eligibility criteria.
They resolved any discrepancies through discussion or
consultation with a third reviewer.
Data extraction and quality assessment
We extracted important information from included sys-
tematic reviews such as study populations, socioeco-
nomic indicator, outcomes, and results. A second
reviewer checked all abstracted data for completeness
and accuracy.
To assess risk of bias (RoB) of systematic reviews, we
used a modified version of the AMSTAR (A Measure-
ment Tool to Assess Systematic Reviews) [9] appraisal
tool. The tool consists of a 14-point checklist for the
presence of a clearly defined research question, compre-
hensive and systematic literature search in multiple data-
bases, dual and independent review and data abstraction
of included studies, dual and independent assessment of
quality of included studies, a clear definition of eligibility
criteria, and, if a meta-analysis had been performed, an
assessment of publication bias and testing, and an ex-
ploration of heterogeneity. We rated the reviews as low,
unclear, or high RoB. Two independent reviewers
assessed the RoB for each systematic review. Disagree-
ments were resolved by discussion or by consulting a
third reviewer.
In general terms, a review categorised as low RoB
implies confidence that results represent true treatment
effects. A review with unclear RoB is susceptible to some
RoB but probably not enough to invalidate its results. A
review assessed as high RoB has significant flaws of
various types (e.g., stemming from serious errors in de-
sign, conduct, or analysis) that may invalidate its results.
Results
Out of 3302 abstracts, we identified 22 eligible systematic
reviews for this research question. Figure 1 documents the
study selection process of this report. Half of included
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studies [10–20], however, received a high RoB rating, mostly
due to a lack of duality in the study selection process and an
omission of a quality assessment of included studies. We
narratively synthesized all included studies by outcome and
order of NCDs or risk factors in Tables 1, 2 and 3 and
below. The full data abstraction tables including RoB
explanations can be found in Additional files 2, 3 and 4.
Incidence or prevalence of non-communicable diseases
Overall, the evidence suggests that having low SES and/
or living in LMIC increases the risk of CVD, lung and
gastric cancer, type 2 diabetes, and COPD. We located a
total of 14 systematic reviews [11, 15–18, 21–29] that in-
vestigated socioeconomic inequalities in relation to in-
cidence or prevalence of NCDs. Seven of them looked
for evidence on socioeconomic inequalities and CVDs
[15–17, 21–24], four for inequalities in incidence or
prevalence of different types of cancers [11, 25–27], an-
other two for inequalities associated with diabetes risk
[18, 28], and one for inequalities and chronic respira-
tory disease risk [29]. Although data from LMIC was
generally scarce, seven systematic reviews provided
between country comparisons based on income level
[16, 21, 22, 24, 26–28] (Table 1).
Cardiovascular diseases
Whilst there are numerous systematic reviews on
socioeconomic inequalities and CVD risk, all of them
were fraught with some methodological shortcomings.
We derived the best available evidence from three
systematic reviews with an unclear RoB that focused
on socioeconomic inequalities in incidence of stroke
[23, 24] and acute myocardial infarction (MI) [22].
We located four additional systematic reviews with high
RoB that reported on the prevalence or incidence of CVD
and subtypes of CVD such as peripheral artery disease
(PAD) and stroke [15–17, 21].
The evidence evaluating associations between SES and
CVD risk is fairly consistent. Kerr et al. [23] pooled data
from 12 studies conducted mostly in HIC and found a
higher risk of stroke incidence in the lowest SES group as
compared to the highest SES group (Hazard ratio [HR]
1.31). This was supported by Sposato and Saposnik [21]
who reported a significant correlation between lower
Fig. 1 PRISMA Flow Diagram of the Study Selection Process
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Table 1 Summary of results for incidence or prevalence of NCDs
Author, Year Population Outcome Results Risk of Bias
Cardiovascular diseases
Age-adjusted mean stroke incidence rates:Feigin et al.,
2009 [24]
General population
in HIC and LMIC
Incidence of stroke
HIC: 42 % reduction from 1970–79 to 2000–08
(p< 0.004); LMIC: >50 % increase from 1970–79
to 2000–08 (p< 0.0001)
Unclear
Stroke mean incidence rates over time by age
groups (1970–79 vs 2000–8):
HIC: 44 % (<75 y) and 41 % (> 75 y) reduction
(both p < 0.0001); LMIC: 2-fold (< 75 y) and almost




in HIC and LMIC
Prevalence of PAD Prevalence of PAD was higher in women from
LMIC than HIC at all ages up to 60–64 years,
above which the prevalence was higher in HIC.
Prevalence of PAD was higher in men from HIC
than LMIC at all ages.
High
Rate of change from 2000 to 2010 was 28.7 %





Incidence or prevalence of overall
CVD, CHD, stroke, other CVD
subtypes
9 out of 9 prospective studies found a higher incident
risk of CVD among those with low childhood SES.
High
7 of 11 case-control studies showed an
association of low childhood SES and risk for
MI, angina, or stroke.
5 cross-sectional studies found a higher prevalence
of CHD among those with low childhood SES.





(all but 1 study)
Incidence of stroke
Unadjusted Meta-analysis (low vs high) Education,
occupation or income: 1.67, 95 % CI: 1.46–1.91 Unclear
Meta-analysis adjusted for grouped vascular risk
factors (low vs high) Education, occupation or
income: 1.31, 95 % CI: 1.16–1.48




in HIC and LMIC
Incidence of acute MI
Meta-analysis across countries (low vs high) Education:
1.34, 95 % CI: 1.22–1.47; Occupation: 1.35. 95 %
CI: 1.19–1.53; Income: 1.71, 95 % CI: 1.43—2.05
Unclear
HIC (low vs high) Education: 1.39, 95 % CI: 1.25–1.55;
Occupation: 1.41, 95 % CI: 1.25–1.59; Income:
1.76, 95 % CI: 1.46–2.12
LMIC (low vs high) Education: 1.16, 95 % CI: 0.97–1.39;
Occupation: 0.51, 95 % CI: 0.27–0.99; Income:







(MI, IHD, carotid IMT;
CHD, AP), stroke
8 out of 9 studies found a higher incident risk
of CVD among those with low childhood SES,
but only few studies reported inverse adjusted
(CVD risk factors and/or adult SES) associations.
2 out of 2 studies showed no significant associations
between stroke risk and childhood SES.
1 study found an association between cumulative life










Lower PPP-aGDP correlated with higher incident risk
of stroke (ρ = -0.661, p = 0.027).
Unclear
Lower PPP-aTHE correlated with higher incident
risk of stroke (ρ = -0.623, p = 0.040).
There were no correlations between unemployment




Children in HIC Incidence of childhood leukaemia Two studies showed an increased risk of leukaemia
in children from deprived areas, 4 studies showed
a decreased risk of leukaemia in children from
deprived areas or lower SES, 1 study found SES
not to be a determinant of leukaemia in children.
High
RR for lung cancer incidence:
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country-level macro-socioeconomic status indicators and
higher risk of stroke incidence. Similarly, the review by
Manrique-Garcia et al. [22] showed an overall increased
risk for acute MI among the lowest SES group for income
(Risk ratio [RR] 1.71), occupation (RR 1.34) and education
(RR 1.35). When analysed by country's income level,




in HIC and MIC
Incidence of lung cancer Meta-analysis, adjusted for smoking, RR (low vs high)
Education: 1.61, 95 % CI: 1.40–1.85; Occupation:
1.48, 95 % CI: 1.34–1.65; Income: 1.37, 95 % CI: 1.06–1.77
Unclear
HIC (low vs high) Education: 1.66, 95 % CI: 1.10–2.51; Occupation:
1.42, 95 % CI: 1.26–1.62; Income: 1.39. 95 % CI: 1.13–1.69
MIC (low vs high) Education: 1.66, 95 % CI: 1.28–2.16;





Incidence of lung cancer 1 study found higher incidence rates of lung cancer
for women and men from all age groups with
Medicaid insurance compared to non-Medicaid.
1 study found higher incidence rates of lung cancer for
Medicare patients alone compared to Medicaid/Medicare
patients, but the effect was removed when the comparison
group was restricted to patients covered by Medicaid
>12 months before diagnosis.
Unclear
RR for lung cancer incidence:Uthman et al.,
2013 [27]
General population
in HIC, MIC, and
LIC
Incidence of gastric cancer
Overall (low vs high) Education: 2.97, 95 % CI:
1.92–4.58; Occupation: 4.33, 95 % CI: 2.57–7.29;
Income: 1.25, 95 % : 0.93–1.68; Combined
SEP: 2.64, 95 % CI:1.05–6.63
Unclear
HIC (low vs high) Education: 2.65, 95 % CI
1.64–4.30; Occupation: 6.79, 95 % CI 3.42–13.50;
Income: 1.09, 95 % CI: 0.76–1.56; Combined
SEP: 4.50, 95 % CI: 0.84–24.16
MIC (low vs high) Education: 5.11, 95 % CI 2.71–9.65;
Occupation: 3.06, 95 % CI 2.10–4.8; Income: 1.48, 95 %
CI: 0.61–3.58; Combined SEP: 1.36, 95 % CI: 0.52–3.60
Type 2 diabetes
RR for type 2 diabetes incidence:Agardh et al.,
2011 [28]
General population
in HIC, MIC, and LIC
Incidence of type 2 diabetes
Overall (low vs high) Education: 1.41, 95 % CI: 1.28–1.51;
Occupation: 1.31, 95 % CI: 1.09–1.57; Income: 1.40,
95 % CI: 1.04–1.88
Unclear
HIC (low vs high) Education: 1.45, 95 % CI: 1.28–1.63;
Occupation: 1.31, 95 % CI: 1.05–1.63; Income: 1.40,
95 % CI: 0.81–2.42
MIC (low vs high) Education: 1.59, 95 % CI: 1.28–1.97;
Occupation: 1.27, 95 % CI: 0.96–1.68; Income: 1.39,
95 % CI: 1.06–1.82
LIC (low vs high; n = 1); Education: –; Occupation: –;




in HIC and MIC
Incidence of type 2 diabetes
in later life
4 out of 6 studies showed an increased risk
of type 2 diabetes in either girls or boys from
low parental occupational status, 2 studies
showed no association. For education,
2 out of 3 studies showed an increased
risk of type 2 diabetes in children from low SES.
1 study showed no statistically significant
association between type 2 diabetes







Prevalence and incidence of
COPD
6 out of 8 studies found individuals of the lowest
SES strata more likely to have or develop.
Low
COPD than those of the highest (point estimates
of OR ranging from 0.8–3.7, RII ranging from 2.2 to 3.2).
RR Relative risk, CI Confidence interval, SES Socioeconomic status, COPD Chronic obstructive pulmonary disease, OR Odds ratio, RII Relative index of inequality,
na not available, SEP Socioeconomic position, y years, vs versus, p p-value, LMIC Low and middle income countries, LIC Low income countries, MIC Middle income
countries, HIC High income countries, PAD Peripheral artery disease, MI Myocardial infarction, CVD Cardiovascular diseases, CHD Coronary heart disease, IHD Ischaemic
heart disease, IMT Intima-media thickness, AP Angina pectoris, PPP-aGDP Per capita GDP adjusted for purchasing power parity, PPP-aTHE total health expenditures per
capita at purchasing power parity, ρ Spearman rank correlation coefficient, n number of studies, NCDs Non-communicable diseases, HR Hazard ratio
aRelative Index of Inequality is an indicator of the degree of inequality across socioeconomic categories
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associations between low SES and higher risk of acute MI
incidence were significant in HIC but not LMIC. However,
the vast majority of the 70 included studies stemmed from
HIC. This imbalance in favour of studies from HIC was
also observed by Feigin et al. [24], who analysed stroke in-
cidence for four study periods and two country income
levels. Over the four study periods, age-adjusted stroke in-
cidence rates in HIC significantly decreased by 42 % (163
to 94 per 100000 person-years), while those in LMIC
more than doubled and exceeded the rate in HIC (52 to
117 per 100000 person-years).
The three systematic reviews with high RoB largely
support the findings from the three other systematic
reviews or report similar results for other CVD sub-
types [15–17]. However, the results from two system-
atic reviews on childhood socioeconomic inequalities
and adult risk of CVD were mixed [15, 17]; the ob-
served inverse associations were often attenuated or
disappeared when adjusting for CVD risk factors or
adult SES [17].
Cancers
We identified four systematic reviews on socioeconomic
inequalities and cancer incidence, with two of them
reporting on lung cancer [25, 26], one on gastric cancer
[27], and another one on childhood leukaemia [11].
However, three of these reviews had an unclear RoB
[25–27] and one a high RoB [11].
The systematic review of 64 studies by Sidorchuk et
al. [26] constitutes the most comprehensive data col-
lection on SES and lung cancer incidence to date. In
their meta-analyses (adjusted for smoking), they found
a statistically significant 1.37 (income) to 1.61 (educa-
tion) higher RR for lung cancer in groups of low SES
than those of high SES. The systematic review by Sla-
tore et al. [25] of two studies on insurance status and
risk of lung cancer in the US showed conflicting
results.
The evidence base for SES and gastric cancer inci-
dence is limited to an unclear-RoB systematic review
encompassing 36 studies from MIC and HIC [27]. Its
meta-analyses yielded results that are largely consistent
with those on lung cancer; the pooled Relative Index of
Inequality (RII) ranged from 2.97 (education) to 4.33
(occupation) for risk of developing gastric cancer in in-
dividuals from the lowest as compared to the highest
SES group. Subgroup analysis at country income level
showed mixed results, which might be explained by the
uneven distribution of studies across country income
level and SES indicators.
One systematic review (high RoB) on SES inequalities
in relation to childhood leukaemia incidence found het-
erogeneous results and therefore no clear evidence to
support an association [11].
Type 2 diabetes
For this outcome we located two systematic reviews.
One review rated as unclear RoB and investigated asso-
ciations between type 2 diabetes incidence and SES
globally and subdivided by country income level [28].
Agardh et al. [28] pooled data from 23 studies and
found an increased risk of type 2 diabetes for individ-
uals in the lowest strata of education (RR 1.41), occupa-
tion (RR 1.31), and income (RR 1.40) as compared with
individuals in the highest strata. Although the majority
of studies were from HIC, subgroup analyses based on
income level of countries supported the results in that
the effect was consistent across LIC, MIC and HIC.
The other systematic review was of high RoB and fo-
cused on childhood SES and risk for type 2 diabetes in
HIC [18]. Six out of ten studies included in the system-
atic review by Tamayo et al. [18] indicate an association
between childhood socioeconomic inequalities and risk
of type 2 diabetes later in life.
Chronic respiratory diseases
Although we only identified one systematic review that
met the eligibility criteria for chronic respiratory diseases,
it is one of the few with low RoB in this overview. The
majority of the studies (6 out of 8) included by Gershon et
al. [29] found that individuals in the lowest SES group had
a significantly increased risk of COPD when compared to
those of the highest SES in HIC.
Adverse outcomes from non-communicable diseases
Systematic reviews show that low SES increases the risk
of mortality from lung cancer, COPD, and reduces breast
cancer survival in HIC. Early case fatalities of stroke are
suggested to be lower and survival of retinoblastoma
higher in MIC compared with LIC.
Overall, we identified ten systematic reviews [10, 15, 17,
20, 21, 24, 25, 29–31] that examined associations between
SES and adverse outcomes of NCDs. Among those ten,
five focused on socioeconomic inequalities and mortality
or fatality from CVDs [15, 17, 21, 24, 30], three on SES
and adverse outcomes from cancer [20, 25, 31], and one
on SES and chronic respiratory disease mortality [29]. One
systematic review provided data on all those outcomes
[10]. We could not find any evidence on socioeconomic
inequalities and adverse outcomes from type 2 diabetes.
Only two systematic reviews compared adverse NCD
outcomes across country income levels (Table 2) [21, 24].
Cardiovascular diseases
The best available evidence of the six systematic reviews
that met the eligibility criteria for CVDs can be derived
from three unclear-RoB systematic reviews [21, 24, 30].
Results from these studies differed from the three
remaining high-RoB systematic reviews [10, 15, 17].
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Table 2 Summary of results adverse outcomes from NCDs
Author, year Population Outcome Results Risk of Bias
Cardiovascular diseases




Mortality in heart failure
after hospitalization
(30 day)
Lower vs higher education:
RR 1.05, 95 % CI: 0.98–1.12 (n = 1) Unclear
Lower vs higher neighbourhood
SES: RR 1.13, 95 % CI: 0.92–1.38 (n = 1)
Medicaid insurance vs other: OR 0.66,
95 % CI: 0.3–1.4 (4 studies, result from one)
≤ 25 miles to hospital vs > 25 miles to
hospital: OR 0.95, 95 % CI: 0.92–0.98 (n = 1)
Early case fatalities of total strokes (%):Feigin et al.,
2009 [24]
Patients with stroke
in HIC and LMIC
Early case fatality of
stroke (21 day to 1
month)
HIC: non-significant reduction from 35.9 %
(1970–79) to 19.8 % (2000–08) Unclear
LMIC: non-significant reduction from 35.2 %





Overall CVD, CHD, stroke,
angina, other CVD
subtypes mortality
19 out of 24 prospective studies found an
association between low childhood SES and
increased risk CVD mortality. In 5 out of 9







Overall CVD, CHD and
stroke mortality
5 out of 9 studies found a higher risk of
overall CVD mortality among those with low
childhood SES, with results generally remaining
statistically significant after adjustment for adult
SES and/or adult CVD risk factors.
High
7 out of 10 studies found a higher risk of CHD
mortality among those with low childhood SES,
although adult SES attenuated the association
in some studies. 4 out of 6 studies found a higher





patients with CVD and
stroke from HIC
CVD, stroke mortality 11 out of 13 studies found a higher risk of
CVD mortality among those with low childhood
SES. Most associations remained statistically
significant after adjustment for CVD risk
factors and/or adult SES.
High
3 out of 3 studies showed a higher risk of
stroke mortality among those with low childhood
SES. Adjustment for adjustment for CVD
risk factors and/or adult SES had
minor impact on the effect.
5 out of 5 studies reported an association
between cumulative life course exposure to
low SES conditions and increased CVD mortality.
Sposato et al.,
2012 [21]
Patients with stroke in




Lower PPP-aGDP correlated with higher 30-day
case-fatality rates of stroke (ρ = -0.713, p < 0.001)
and a greater proportion of intracerebral
hemorrhages (ρ = -0.689, p < 0.001).
Unclear
Lower PPP-aTHE correlated with higher 30-day
case-fatality rates of stroke (ρ = -0.701, p < 0.001)
and a greater proportion of intracerebral
hemorrhages (ρ = -0.643, p < 0.001).
There was no correlation between unemployment
and 30-day case-fatality rates of stroke
(ρ = 0.204; p = 0.32) and proportion of
intracerebral hemorrhages
(ρ = -0.258, p = 0.184).
Cancers




MIC, lower MIC, and LIC
Survival of
retinoblastoma Upper MIC: 79 % (range, 54–93 %);
UnclearLower MIC: 77 % (range, 60–92 %)
LIC: 40 % (range, 23–70 %)→ p = 0.001
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In particular, Feigin et al. [24] found that early stroke
case fatality rates (21 days to 1 month) from 2000 to 2008
were 25 % higher in LMIC than HIC (26.6 % vs 19.8 %).
Likewise, lower country macro-socioeconomic status indi-
cators but not unemployment rate was significantly corre-
lated with higher 30-day case-fatality rates of stroke and a
greater proportion of intracerebral haemorrhages in an-
other systematic review [21]. The review by Calvillo-King
et al. [30] showed no associations between short-term
mortality in heart failure and education, neighbourhood
SES, and insurance status (e.g. lower vs higher education:
RR 1.05). The majority of studies included in the three
other high-RoB reviews again found a greater risk for
overall CVD, coronary heart disease or stroke mortality
under poorer childhood socioeconomic circumstances,
which was often attenuated by adult SES [10, 15, 17].
Cancers
The four systematic reviews that looked for evidence on SES
and adverse cancer outcomes are heterogeneous in their study
populations and outcomes, but rather homogenous in their
results [10, 20, 25, 31]. We rated two of them as unclear RoB
[25, 31] and two with high RoB [10, 20].
The review by Canturk et al. [31] found that survival of
retinoblastoma was significantly lower in LIC as compared
to MIC (40 % vs 77 %–79 %). Similarly, results of the review








4 out of 5 studies found no association between
overall cancer mortality and childhood SES, and
the effect was removed by adjustment for adult
SES in the remaining study. 3 out of 3 studies found
a higher risk of lung cancer mortality among those
with low childhood SES, although the association
was largely explained by adults SES in 2 studies.
1 study showed no association of childhood SES with
other smoking-related cancers.
High
1 study found a higher risk of stomach cancer
mortality among those with low childhood SES.
1 study found a higher risk of large-bowl and
rectal cancer among those who had the poorest
housing conditions during childhood.
There was no association between non-smoking
related cancers (3 studies), prostate cancer (1 study)





cancer in the US and
Canada
Breast cancer survival Within Canada, there was no association between
area-SES and breast cancer survival, a little survival
disadvantage was only observed for lowest vs.
highest income areas (pooled RR 0.94, 95 % CI 0.93–0.95).
High
Within the US, breast cancer survival was consistently
associated with area-SES. Women with breast cancer
from low and middle income areas had survival
disadvantage compared to women from high income
areas (pooled RR ranging from 0.73, 95 % CI 0.72–0.74




cancer in the US
Lung cancer mortality 4 out of 4 studies showed a higher risk for lung cancer
mortality for Medicaid insurance vs. other or private insurance.
2 studies showed mixed results on the association between
Medicare vs Medicaid/Medicare and lung cancer mortality.
1 study showed a higher risk for lung cancer mortality for
Medicare insurance and no insurance compared to private
insurance. 2 studies showed no association between lung
cancer mortality and insurance status. 1 study found mixed







COPD mortality 1 study did not find an association between higher






COPD mortality Individuals of the lowest SES consistently had significantly
higher mortality from COPD than those of the highest,
except for 1 study (out of 5) where income was not
associated with COPD mortality.
Low
SES Socioeconomic status, COPD Chronic obstructive pulmonary disease, RR Relative risk, OR Odds ratio, CI Confidence interval, p p-value, n number of studies, US
United States, PPP-aGDP Per capita GDP adjusted for purchasing power parity, PPP-aTHE total health expenditures per capita at purchasing power parity, ρ
Spearman rank correlation coefficient, y years, NCDs Non-communicable diseases, vs versus, LMIC Low and middle income countries, LIC Low income countries,
MIC Middle income countries, HIC High income countries, PAD Peripheral artery disease, MI Myocardial infarction, CVD Cardiovascular diseases, CHD Coronary heart
disease, IHD Ischaemic heart disease, IMT Intima-media thickness, AP Angina pectoris
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by Slatore et al. [25] were less conclusive but indicated high
lung cancer mortality in patients on a social health care
programme as compared to others. These findings were
upheld by Galobardes et al. [10] who found that adult SES
explained the observed associations between low childhood
SES and increased risk of lung cancer mortality. No associ-
ations were seen between childhood SES and overall cancer
mortality, as well as most other types of cancer mortality
such as prostate cancer mortality. The review by Gorey
et al. [20] showed that US women from low and middle
income areas had worse 5-year breast cancer survival rates
compared to high-income areas (pooled RR 0.73 and 0.96).
In Canada, the survival disadvantage was minor and only
observed in women from low compared to high-income
areas (pooled RR 0.94).
Chronic respiratory diseases
Although we located two systematic reviews on SES in
relation to chronic respiratory diseases, only one has a low
RoB. This review reported significantly higher mortality
Table 3 Summary of results for incidence or prevalence of NCD risk factors
Author, year Population Outcome Results Risk of Bias
Obesity
Prevalence (overweight [obesity])
in urban area (n = 1):
Ekpenyong and
Akpan, 2013 [19]
Adults in Nigeria Prevalence of overweight
and obesity
Low SES: 24.8 % [12.9 %]; Medium SES:
18.9 % [5.7 %]; High SES: 14.6 % [4.9 %] High
Prevalence:Papandreou et al.,
2008 [13]
Children and adults in
Mediterranean countries
Prevalence of obesity
Children HIC vs MIC: 11.5 % vs 3.9 %
(p = 0.071) [m]; 7.2 % vs 3.2 % (p = 0.074) [w] High
Adults HIC vs MIC: 20.1 % vs 22.0 %
(p = 0.62) [m]; 24.4 % vs 30.2 % (p = 0.368) [w]
Shrewsbury and
Wardle, 2008 [12]
Children in HIC Prevalence of childhood
obesity
19 out of 45 studies found higher obesity
prevalence rates among those with low SES
(all indicators), 12 studies found no and
14 varied associations.
High
15 out of 20 studies found higher obesity
prevalence rates among those with low education,
1 study found no, and 4 varied associations.
5 out of 13 studies found higher obesity
prevalence rates among those with low occupation,
6 studies found no, and 2 varied associations.
4 out of 11 studies found higher obesity prevalence
rates among those with low income, 3 studies
found no, and 4 varied associations.
2 out of 5 studies found higher obesity prevalence
rates among those with low SES (composite measures),
1 study found no, and 2 varied associations.
2 out of 7 studies found higher obesity prevalence
rates among those with low neighbourhood SES,






of overweight and obesity in
later childhood/life
5 studies showed no direct or a small influence
of education on later childhood overweight and
obesity, 2 studies showed an increased risk for
overweight and obesity in the lowest education strata.
High
No or small associations between occupation and
overweight or obesity were found in 4 studies, of
which 2 reported on adult overweight and obesity.
2 studies reported an increased risk of later childhood
overweight and obesity in the lowest occupation strata.
3 studies observed effects regarding income
discrepancies and later childhood overweight
and obesity, 2 studies showed no associations.
Prevalence ratios (NHANESa data):Wang and Beydoun,
2007 [14]
US adults and children Prevalence of overweight
and obesity Adults (obesity) Low vs high SES: 1.6 (m), 3.4 (w)
in 1971–74; 1.1 (m), 1.3 (w) in 1999–2000. High
Children aged 2–9 y (overweight) Low vs high
SES: 1.9 (m), 0.8 (f) in 1971–75; 1.8 (m), 1.0 (f)
in -1999–2002.
Children aged 10–17 y (overweight) Low vs high SES: 0.8
(m), 2.0 (f) in 1971–75; 1.1 (m), 1.6 (f) in 1999–2002.
m men or male, w women, f female, SES Socioeconomic status, vs versus, US United States, y years, n number of studies, HIC High income country, MIC Middle
income country, NCDs non-communicable diseases
aNational Health and Nutrition Examination Surveys (USA)
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from COPD for individuals of the lowest SES compared to
the highest in HIC (4 out of 5 studies) [29]. The other
review, however, has a high RoB and included data from
only one study [10].
Incidence or prevalence of risk factors for non-
communicable diseases
Because we could not locate any systematic reviews on
SES in relation to tobacco use or alcohol consumption,
the available evidence is restricted to obesity (Table 3).
Obesity
Systematic reviews included here indicate that lower SES
is a risk factor for obesity in HIC, but this association
varies by SES measure.
We found five systematic reviews on SES in relation to
prevalence or incidence of obesity, all of which were rated
as high RoB [12–14, 18, 19]. Three of them assessed the
impact of SES inequality on obesity in HIC [12, 14, 18], one
in a LIC [19], and one compared obesity prevalence between
high and middle income Mediterranean countries [13].
Tamayo et al. [18] and Shrewsbury and Wardle [12] drew
from different study designs in order to investigate child-
hood SES inequalities in relation to childhood obesity. While
both systematic reviews reported some studies that showed
an increased risk or prevalence for childhood obesity in
children with low parental occupation, the results from
studies employing parental education or income as measures
of SES are conflicting. Nevertheless, neither review located
any studies demonstrating associations between high SES
and increased risk or prevalence of childhood obesity.
In an earlier systematic review on US obesity data, Wang
and Beydoun [14] reported higher prevalence rates of obes-
ity among adults (ratio 1.1 in men and 1.3 in women),
young boys (ratio 1.8), and adolescent girls (ratio 1.6) from
the lowest SES group than individuals from the highest
SES group. We located an additional systematic review that
also compared obesity prevalence rates across age groups,
but stratified by income levels of Mediterranean countries
[13]. While obesity rates for children were lower in MIC
than HIC (male 3.9 % vs 11.5 %; female 3.2 % vs 7.2 %),
adults from MIC had higher obesity rates than those from
HIC (male 22.0 % vs 20.1 %; female 30.2 % vs 24.4 %).
Only one systematic review collated evidence from
LIC. Ekpenyong and Akpan [19] identified one eligible
study from Nigeria showing that prevalence of over-
weight and obesity is higher in individuals in the lowest
SES strata than in the highest SES strata (overweight
[obesity]: 24.8 % [12.9 %] vs 14.6 % [4.9 %].
Discussion
This overview of reviews aimed to provide a comprehensive
overview of the evidence from systematic reviews on: the
prevalence and incidence of NCDs, adverse outcomes from
NCDs (mortality or survival time), and incidence or preva-
lence of risk factors for NCDs, by SES, and income level of
countries. Overall, socioeconomic inequalities in relation to
NCDs and their risk factors exist, but the located evidence
is sparse and limited to only some NCDs in predominately
HIC. A number of research gaps that require future investi-
gation have arisen as a consequence thereof.
Systematic reviews on socioeconomic differentials and
incidence or prevalence of NCDs suggest that low SES in-
creases the risk for acute MI and stroke in HIC. Further-
more, evidence indicates that stroke incidence rates in
LMIC are on the rise and exceed the rates in HIC, which
are decreasing. In the case of adverse CVD outcomes,
there is evidence suggesting that early case fatality rates of
stroke are higher in LMIC than HIC, and there is insuffi-
cient evidence on socioeconomic inequalities and short-
term mortality in heart failure in HIC. Although there is
evidence to support increased risk of adult CVD incidence
and mortality under poorer childhood socioeconomic cir-
cumstances, it was derived from high-RoB reviews and
therefore constitutes an area for improvement. Similarly,
other types of CVD incidences, prevalence rates or adverse
outcomes in relation to SES and income level of countries
have not been systematically investigated.
Systematic reviews that examined the association
between cancer incidence or prevalence and socioeco-
nomic inequalities are limited to lung and gastric cancers,
demonstrating the need to examine other forms of cancer.
These studies do however suggest that low SES is corre-
lated with an increased risk for developing lung and gas-
tric cancer. We did not anticipate locating a review on
retinoblastoma, a rare childhood cancer caused by genetic
mutation [32], suggesting that estimated survival is lower
in LIC than MIC. In terms of other cancer outcomes, evi-
dence is limited to lung cancer mortality and SES in HIC
as all other associations on socioeconomic inequalities
and cancer outcomes were reported in high-RoB reviews
and do not provide sound evidence. Considering that liver,
colorectal, and oesophageal cancers are also major causes
of cancer-related mortality worldwide [33], more system-
atic reviews exploring the relationship between those
cancers and socioeconomic inequalities or income levels
of countries are warranted.
In regard to type 2 diabetes, available data from HIC and
MIC indicates an increased risk for individuals from low
SES as compared with individuals from high SES. Thus,
data on diabetes risk and socioeconomic inequalities, as
well as between socioeconomic inequalities and risk for
type 2 diabetes later in life, present another gap in the
evidence base. The only systematic review we identified on
that topic was of high RoB and reported mixed results.
Likewise, there is no systematic review on socioeconomic
differentials and adverse outcomes from type 2 diabetes.
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The strongest evidence of this overview comes from a
low-RoB systematic review, which showed an increased
risk for COPD incidence and mortality within low SES
populations from HIC. In addition to the absence of
evidence on social inequalities and COPD within LMIC,
it is surprising that we did not identify any systematic
review on asthma, which affects 300 000 million chil-
dren and adults worldwide [34].
The topic most lacking in well-conducted reviews was
socioeconomic disparities and risk factors for NCDs. Unex-
pectedly, we only found four systematic reviews on incidence
or prevalence of obesity, all of which were of poor quality
and included heterogeneous study designs, SES measures,
populations, and age groups. As expected, the results from
these reviews show a clear trend towards an association
between low SES and increased risk of obesity. However, this
trend needs to be confirmed by well-conducted systematic
reviews on all age groups, including both childhood and
adult SES. Further areas in need of review are the SES
patterns of obesity in LMIC and comparisons of obesity
prevalence and incidence between LMIC and HIC. We also
found no reviews on SES inequalities in relation to tobacco
use or alcohol consumption, both of which are important is-
sues. In 2010, tobacco use (including second-hand smoke)
(6.3 %) and alcohol use (5.5 %) followed hypertension (7.0 %)
as the leading risk factors for the global disease burden [35].
Finally, it is worth noting that even though most re-
views set out to include data from LMIC, they ended up
with a strong imbalance in favour of studies from HIC.
The lack of studies in LMIC points out the need for
more research among these study populations in order
to be able to assess socioeconomic inequalities within as
well as among LMIC and HIC countries.
Limitations
The major limitation of this overview is that the evidence
is mainly based on poorly conducted systematic reviews.
Out of 22, we identified a total of eleven systematic
reviews [10–20] with shortcomings in the study selection
and quality assessment process. Only one systematic
review had a low RoB [29]. The limited number of well-
conducted systematic reviews highlights the need for
more reviews that apply rigorous methods. Another chal-
lenge common to all overviews of systematic reviews is
publication bias. The search strategy was designed to in-
clude as many relevant systematic reviews as possible, but
there might be others that we inadvertently omitted for
this overview. Despite this inevitable fact, we believe that
we have uncovered real gaps in the evidence base. Finally,
we cannot rule out any potential overlap in the included
primary studies between the systematic reviews that
answered the same question regarding SES measures and
outcomes. As this concerns mainly high-RoB systematic
reviews whose results are deemed to be highly uncertain
(for example Galobardes et al. [15] and Pollitt et al. [17]),
the impact of the overlap on the evidence base is
negligibly small.
Conclusion
The systematic review evidence generally supports an as-
sociation between socioeconomic inequalities and NCDs
and/or risk factors for NCDs. However, this association is
limited by the poor methodological quality of the reviews.
Furthermore, there appear to be several gaps in the evi-
dence base, which has led us to identify important topics
for future research. This particularly concerns data from
LMIC countries. Despite the efforts of authors of system-
atic reviews to include studies from LMIC, only a few
were successful, thereby preventing any cross-country
comparisons by country income level. There is also an
unexpected lack of systematic reviews on socioeconomic
inequalities and several types of cancers, asthma, and
tobacco and alcohol use outcomes. Finally, it is important
to compile evidence on childhood SES and NCDs and/or
their risk factors, as the findings might be different than
the associations with adulthood SES.
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